Bayer Runs Into ‘Devil’s Advocate’ in Roundup Cancer Case
- Shares plunge after judge says company is responsible
- Expert weighed ‘everything but the elephant,’ company argued
This article is for subscribers only.
Bayer AG seemed to have the judge on its side as it sought to overturn the first jury verdict on Roundup weed killer. But it didn’t work out that way.
Monday’s ruling finding the company responsible for a groundskeeper’s cancer was remarkable in how it departed radically from a California state judge’s tentative order and her questioning of lawyers less than two weeks earlier. The outcome has the potential to shape thousands of similar cases filed in courts across the U.S.